{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:00:09Z","timestamp":1791453609119,"version":"4.3.3"},"reference-count":344,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.brainres.2025.149693","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T19:12:22Z","timestamp":1746817942000},"page":"149693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Neuroprotective potential of epigallocatechin gallate in Neurodegenerative Diseases: Insights into molecular mechanisms and clinical Relevance"],"prefix":"10.1016","volume":"1860","author":[{"given":"Md. Al","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrukh","family":"Zehravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherouk Hussein","family":"Sweilam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mst Maharunnasa","family":"Shatu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trupti Pratik","family":"Durgawale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Shamim","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Durgapal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Akiful","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshwar","family":"Vodeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam Prasad","family":"Panigrahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharuk L","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha Bin","family":"Emran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0005","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/ijms23031851","article-title":"A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics","volume":"23","author":"Lamptey","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.brainres.2025.149693_b0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmech.2017.09.001","article-title":"Anti-inflammatory effects of flavonoids in neurodegenerative disorders","volume":"153","author":"Spagnuolo","year":"2018","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"7","key":"10.1016\/j.brainres.2025.149693_b0015","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10495-023-01848-y","article-title":"Apoptosis in Alzheimer\u2019s disease: insight into the signaling pathways and therapeutic avenues","volume":"28","author":"Kumari","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.brainres.2025.149693_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102955","article-title":"Oxygen metabolism abnormality and Alzheimer's disease: An update","author":"Liu","year":"2023","journal-title":"Redox Biology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0025","first-page":"31","article-title":"Perspective on metal-ligand coordination complexes and improvement of current drugs for neurodegenerative diseases (NDDs)","volume":"6","author":"Yusuf","year":"2023","journal-title":"Advanced Journal of Chemistry-Section A"},{"issue":"9770","key":"10.1016\/j.brainres.2025.149693_b0030","first-page":"1019","volume":"377","author":"Ballard","year":"2011","journal-title":"\u201calzheimer's Disease,\u201d The, Lancet"},{"key":"10.1016\/j.brainres.2025.149693_b0035","article-title":"\u201cMolecular and Mathematical Models in Parkinson\u2019s and Alzheimer\u2019s Diseases","author":"Erdag","year":"2024","journal-title":"Optimizing the Timing of Drugs,\u201c"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1474-4422(13)70257-6","article-title":"Alzheimer's disease and other dementias: advances in 2013","volume":"13","author":"Reiman","year":"2014","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.14283\/jpad.2023.61","article-title":"Burden of illness in people with Alzheimer's disease: a systematic review of epidemiology, comorbidities and mortality","volume":"11","author":"Lanct\u00f4t","year":"2024","journal-title":"The Journal of Prevention of Alzheimer's Disease"},{"key":"10.1016\/j.brainres.2025.149693_b0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.parkreldis.2021.08.013","article-title":"The effect of Origanum majorana tea on motor and non-motor symptoms in patients with idiopathic Parkinson's disease: A randomized controlled pilot study","volume":"91","author":"Chahra","year":"2021","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/j.brainres.2025.149693_b0055","article-title":"Neurodegenerative diseases and catechins:(\u2212)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress","volume":"11","author":"Li","year":"2024","journal-title":"Frontiers in Nutrition"},{"key":"10.1016\/j.brainres.2025.149693_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106000","article-title":"Update: Descriptive epidemiology of Parkinson disease","volume":"120","author":"Grotewold","year":"2024","journal-title":"Parkinsonism & Related Disorders"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b0065","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037297","article-title":"Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment","volume":"103","author":"Haki","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.brainres.2025.149693_b0070","article-title":"Targeting microglial \u03b1-synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s disease","volume":"12","author":"Li","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.brainres.2025.149693_b0075","doi-asserted-by":"crossref","unstructured":"S. Tripathi, G. Kharkwal, R. Mishra, and G. Singh, \u201cNuclear factor erythroid 2-related factor 2 (Nrf2) signaling in heavy metals-induced oxidative stress,\u201d Heliyon, 2024.","DOI":"10.1016\/j.heliyon.2024.e37545"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b0080","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1474-4422(23)00038-8","article-title":"Chronic effects of inflammation on tauopathies","volume":"22","author":"Langworth-Green","year":"2023","journal-title":"The Lancet Neurology"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b0085","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s11427-023-2336-1","article-title":"Oxidative eustress: the physiological role of oxidants","volume":"66","author":"Sies","year":"2023","journal-title":"Science China Life Sciences"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"7","key":"10.1016\/j.brainres.2025.149693_b0095","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","article-title":"Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration","volume":"19","author":"Patani","year":"2023","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/j.brainres.2025.149693_b0100","doi-asserted-by":"crossref","unstructured":"H. Yu et al., \u201cMetabolic reprogramming and polarization of microglia in Parkinson\u2019s disease: Role of inflammasome and iron,\u201d Ageing research reviews, p. 102032, 2023.","DOI":"10.1016\/j.arr.2023.102032"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0110","article-title":"Green tea extracts epigallocatechin\u20103\u2010gallate for different treatments","volume":"2017","author":"Chu","year":"2017","journal-title":"BioMed Research International"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.31083\/j.jin2303053","article-title":"Brain Mitochondria as a Therapeutic Target for Carnosic Acid","volume":"23","author":"Infantino","year":"2024","journal-title":"Journal of Integrative Neuroscience"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/10408398.2022.2104805","article-title":"Epigallocatechin gallate as a nutraceutical to potentially target the metabolic syndrome: Novel insights into therapeutic effects beyond its antioxidant and anti-inflammatory properties","volume":"64","author":"Ntamo","year":"2024","journal-title":"Critical Reviews in Food Science and Nutrition"},{"key":"10.1016\/j.brainres.2025.149693_b0125","first-page":"1321","article-title":"\u201cNeuroprotection induced by epigallocatechin-3-gallate,\u201d in Natural molecules in neuroprotection and neurotoxicity","author":"Tripathi","year":"2024","journal-title":"Elsevier"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2025.149693_b0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000085385","article-title":"Multifunctional activities of green tea catechins in neuroprotection","volume":"14","author":"Mandel","year":"2005","journal-title":"Neurosignals"},{"key":"10.1016\/j.brainres.2025.149693_b0135","doi-asserted-by":"crossref","unstructured":"S. Ibrahim, I. Riwanto, C. Suharti, A. Putra, S. Budijitno, and Y. W. Prajoko, \u201cUnlocking the Potential: Integrative Effects of 5-Fluorouracil and Epigallocatechin-3-Gallate on Colorectal Cancer Stem Cell Regulation,\u201d 2024.","DOI":"10.33371\/ijoc.v18i2.1211"},{"key":"10.1016\/j.brainres.2025.149693_b0140","article-title":"\u201cThe Effectiveness of Epigallocatechin Gallate (EGCG) Eye Drops to Interleukin-1\u00df and Matrix Metalloproteinase (MMP)-9 Expression in Pseudomonas Aeruginosa Keratitis","author":"Karima","year":"2024","journal-title":"An in Vitro Approach,\u201c"},{"key":"10.1016\/j.brainres.2025.149693_b0145","unstructured":"A. Karima, D. Lutfi, I. Zuhria, F. F. S. Nur, and T. Y. Urolita, \u201cAnti-Inflammatory Effect of Epigallocatechin Gallate on Tumor Necrosis Factor-Alpha and Interleukin-10 Expression in Pseudomonas aeruginosa-Induced Keratitis,\u201d 2024."},{"key":"10.1016\/j.brainres.2025.149693_b0150","unstructured":"H. Rasoulijazi, M. Joghataei, M. Noubakht, and M. Roughani, \u201cThe beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer\u2019s disease in rat: A behavioral analysis,\u201d 2007."},{"key":"10.1016\/j.brainres.2025.149693_b0155","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1007\/s11064-016-1995-9","article-title":"Epigallocatechin gallate (EGCG) inhibits alpha-synuclein aggregation: A potential agent for Parkinson\u2019s disease","volume":"41","author":"Xu","year":"2016","journal-title":"Neurochemical Research"},{"issue":"12","key":"10.1016\/j.brainres.2025.149693_b0160","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.3390\/nu12123792","article-title":"Possible reduction of cardiac risk after supplementation with epigallocatechin gallate and increase of ketone bodies in the blood in patients with multiple sclerosis. A pilot study","volume":"12","author":"Benlloch","year":"2020","journal-title":"Nutrients"},{"issue":"18","key":"10.1016\/j.brainres.2025.149693_b0165","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/ddl210","article-title":"Green tea (\u2212)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models","volume":"15","author":"Ehrnhoefer","year":"2006","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.brainres.2025.149693_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132135","article-title":"Epigallocatechin 3-gallate: From green tea to cancer therapeutics","volume":"379","author":"Alam","year":"2022","journal-title":"Food Chemistry"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0175","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/biom12030371","article-title":"Epigallocatechin-3-Gallate (EGCG): New therapeutic perspectives for neuroprotection, aging, and neuroinflammation for the modern age","volume":"12","author":"Payne","year":"2022","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.brainres.2025.149693_b0180","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700294","article-title":"Blood\u2013brain barrier permeability of green tea catechin metabolites and their neuritogenic activity in human neuroblastoma SH\u2010SY5Y cells","volume":"61","author":"Unno","year":"2017","journal-title":"Molecular Nutrition & Food Research"},{"issue":"38","key":"10.1016\/j.brainres.2025.149693_b0185","doi-asserted-by":"crossref","first-page":"9200","DOI":"10.1021\/jf4023004","article-title":"Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages","volume":"61","author":"Zhang","year":"2013","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.1016\/j.brainres.2025.149693_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2019.103732","article-title":"Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review","volume":"65","author":"Dai","year":"2020","journal-title":"Journal of Functional Foods"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b0195","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14189","article-title":"Epigallocatechin gallate: Phytochemistry, bioavailability, utilization challenges, and strategies","volume":"46","author":"Mehmood","year":"2022","journal-title":"Journal of Food Biochemistry"},{"issue":"19","key":"10.1016\/j.brainres.2025.149693_b0200","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1080\/10408398.2023.2170972","article-title":"Absorption, metabolism, bioactivity, and biotransformation of epigallocatechin gallate","volume":"64","author":"Zhang","year":"2024","journal-title":"Critical Reviews in Food Science and Nutrition"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b0205","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1080\/10408398.2016.1231168","article-title":"Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review","volume":"58","author":"Gan","year":"2018","journal-title":"Critical Reviews in Food Science and Nutrition"},{"issue":"10","key":"10.1016\/j.brainres.2025.149693_b0210","doi-asserted-by":"crossref","first-page":"3262S","DOI":"10.1093\/jn\/133.10.3262S","article-title":"Mechanisms of cancer prevention by tea constituents","volume":"133","author":"Lambert","year":"2003","journal-title":"The Journal of Nutrition"},{"issue":"1\u20134","key":"10.1016\/j.brainres.2025.149693_b0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/biof.5520130110","article-title":"Absorption, metabolism and antioxidative effects of tea catechin in humans","volume":"13","author":"Miyazawa","year":"2000","journal-title":"Biofactors"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085520","article-title":"Use of positron emission tomography for real-time imaging of biodistribution of green tea catechin","volume":"9","author":"Shimizu","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.brainres.2025.149693_b0225","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1093\/jn\/133.12.4172","article-title":"Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice","volume":"133","author":"Lambert","year":"2003","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.brainres.2025.149693_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.907986","article-title":"The influence of EGCG on the pharmacokinetics and pharmacodynamics of Bisoprolol and a new method for simultaneous determination of EGCG and Bisoprolol in rat plasma","volume":"9","author":"Zeng","year":"2022","journal-title":"Frontiers in Nutrition"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b0235","first-page":"1045","article-title":"Absorption, distribution, and elimination of tea polyphenols in rats","volume":"25","author":"Chen","year":"1997","journal-title":"Drug Metabolism and Disposition"},{"issue":"15","key":"10.1016\/j.brainres.2025.149693_b0240","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.3390\/ijms20153630","article-title":"Function of green tea catechins in the brain: Epigallocatechin gallate and its metabolites","volume":"20","author":"Pervin","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/j.brainres.2025.149693_b0245","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1039\/D0FO00524J","article-title":"Effects of EGCG on depression-related behavior and serotonin concentration in a rat model of chronic unpredictable mild stress","volume":"11","author":"Li","year":"2020","journal-title":"Food & Function"},{"key":"10.1016\/j.brainres.2025.149693_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132358","article-title":"EGCG attenuates the neurotoxicity of methylglyoxal via regulating MAPK and the downstream signaling pathways and inhibiting advanced glycation end products formation","volume":"384","author":"He","year":"2022","journal-title":"Food Chemistry"},{"key":"10.1016\/j.brainres.2025.149693_b0255","doi-asserted-by":"crossref","unstructured":"K. Andrich and J. Bieschke, \u201cThe Effect of (\u2212)-Epigallo-catechin-(3)-gallate on amyloidogenic proteins suggests a common mechanism,\u201d Natural Compounds as Therapeutic Agents for Amyloidogenic Diseases, pp. 139-161, 2015.","DOI":"10.1007\/978-3-319-18365-7_7"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13027-017-0145-6","article-title":"The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer\u2019s disease: an overview of pre-clinical studies and translational perspectives in clinical practice","volume":"12","author":"Cascella","year":"2017","journal-title":"Infectious Agents and Cancer"},{"issue":"7","key":"10.1016\/j.brainres.2025.149693_b0265","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0798-822","article-title":"\u03b2-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy","volume":"4","author":"Soto","year":"1998","journal-title":"Nature Medicine"},{"issue":"6968","key":"10.1016\/j.brainres.2025.149693_b0270","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02265","article-title":"Therapeutic approaches to protein-misfolding diseases","volume":"426","author":"Cohen","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0275","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid \u03b2-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b0280","first-page":"2216","article-title":"Epigallocathechin-3-gallate in AL amyloidosis: a new therapeutic option?","volume":"110","author":"Hunstein","year":"2007","journal-title":"Blood, the Journal of the American Society of Hematology"},{"issue":"17","key":"10.1016\/j.brainres.2025.149693_b0285","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"49","key":"10.1016\/j.brainres.2025.149693_b0290","doi-asserted-by":"crossref","first-page":"10624","DOI":"10.1021\/bi2012383","article-title":"Black tea theaflavins inhibit formation of toxic amyloid-\u03b2 and \u03b1-synuclein fibrils","volume":"50","author":"Grelle","year":"2011","journal-title":"Biochemistry"},{"issue":"31","key":"10.1016\/j.brainres.2025.149693_b0295","doi-asserted-by":"crossref","first-page":"21299","DOI":"10.1074\/jbc.M114.554667","article-title":"How Epigallocatechin Gallate Can Inhibit \u03b1-Synuclein Oligomer Toxicity in Vitro","volume":"289","author":"Lorenzen","year":"2014","journal-title":"Journal of Biological Chemistry"},{"issue":"37","key":"10.1016\/j.brainres.2025.149693_b0300","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/bi100939a","article-title":"The flavanol (\u2212)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity","volume":"49","author":"Meng","year":"2010","journal-title":"Biochemistry"},{"issue":"4\u20135","key":"10.1016\/j.brainres.2025.149693_b0305","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jmb.2012.01.013","article-title":"Structural properties of EGCG-induced, nontoxic Alzheimer's disease A\u03b2 oligomers","volume":"421","author":"del Amo","year":"2012","journal-title":"Journal of Molecular Biology"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b0310","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3233\/JAD-2011-111061","article-title":"Identification of polyphenolic compounds and black tea extract as potent inhibitors of lipid membrane destabilization by A\u03b2 42 aggregates","volume":"27","author":"Gauci","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b0315","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nature Structural & Molecular Biology"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b0320","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1021\/ac303181q","article-title":"Surface plasmon resonance imaging of amyloid-\u03b2 aggregation kinetics in the presence of epigallocatechin gallate and metals","volume":"85","author":"Cheng","year":"2013","journal-title":"Analytical Chemistry"},{"issue":"10","key":"10.1016\/j.brainres.2025.149693_b0325","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1073\/pnas.1220326110","article-title":"Insights into antiamyloidogenic properties of the green tea extract (\u2212)-epigallocatechin-3-gallate toward metal-associated amyloid-\u03b2 species","volume":"110","author":"Hyung","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0330","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1039\/c3mt20106f","article-title":"Electroanalysis of the interaction between (\u2212)-epigallocatechin-3-gallate (EGCG) and amyloid-\u03b2 in the presence of copper","volume":"5","author":"Zhang","year":"2013","journal-title":"Metallomics"},{"issue":"41","key":"10.1016\/j.brainres.2025.149693_b0335","doi-asserted-by":"crossref","first-page":"11879","DOI":"10.1021\/jp202640b","article-title":"Molecular insight into conformational transition of amyloid \u03b2-peptide 42 inhibited by (\u2212)-epigallocatechin-3-gallate probed by molecular simulations","volume":"115","author":"Liu","year":"2011","journal-title":"The Journal of Physical Chemistry B"},{"issue":"35","key":"10.1016\/j.brainres.2025.149693_b0340","doi-asserted-by":"crossref","first-page":"11576","DOI":"10.1021\/jp1001435","article-title":"Thermodynamic analysis of the molecular interactions between amyloid \u03b2-peptide 42 and (\u2212)-epigallocatechin-3-gallate","volume":"114","author":"Wang","year":"2010","journal-title":"The Journal of Physical Chemistry B"},{"issue":"20","key":"10.1016\/j.brainres.2025.149693_b0345","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1021\/jp209406t","article-title":"Thermodynamic analysis of the molecular interactions between amyloid \u03b2-protein fragments and (\u2212)-epigallocatechin-3-gallate","volume":"116","author":"Wang","year":"2012","journal-title":"The Journal of Physical Chemistry B"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0350","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1021\/ar4002075","article-title":"Understanding amyloid fibril nucleation and A\u03b2 oligomer\/drug interactions from computer simulations","volume":"47","author":"Nguyen","year":"2014","journal-title":"Accounts of Chemical Research"},{"issue":"15","key":"10.1016\/j.brainres.2025.149693_b0355","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1021\/jp312573y","article-title":"Molecular mechanism of the inhibition of EGCG on the Alzheimer A\u03b21\u201342 dimer","volume":"117","author":"Zhang","year":"2013","journal-title":"The Journal of Physical Chemistry B"},{"issue":"39","key":"10.1016\/j.brainres.2025.149693_b0360","doi-asserted-by":"crossref","first-page":"13720","DOI":"10.1021\/jacs.7b05012","article-title":"Molecular mechanism for the (\u2212)-epigallocatechin gallate-induced toxic to nontoxic remodeling of A\u03b2 oligomers","volume":"139","author":"Ahmed","year":"2017","journal-title":"Journal of the American Chemical Society"},{"issue":"12","key":"10.1016\/j.brainres.2025.149693_b0365","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/acschemneuro.0c00277","article-title":"Green tea extracts EGCG and EGC display distinct mechanisms in disrupting A\u03b242 protofibril","volume":"11","author":"Zhan","year":"2020","journal-title":"ACS Chemical Neuroscience"},{"issue":"15","key":"10.1016\/j.brainres.2025.149693_b0370","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.3390\/ijms21155462","article-title":"Insights into the effect of curcumin and (\u2013)-epigallocatechin-3-gallate on the aggregation of A\u03b2 (1\u201340) monomers by means of molecular dynamics","volume":"21","author":"Tavanti","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"6\u20137","key":"10.1016\/j.brainres.2025.149693_b0375","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1078\/094471103322331449","article-title":"Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract","volume":"10","author":"Melzig","year":"2003","journal-title":"Phytomedicine"},{"key":"10.1016\/j.brainres.2025.149693_b0380","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroscience.2017.08.030","article-title":"Epigallocatechin gallate induces extracellular degradation of amyloid \u03b2-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways","volume":"362","author":"Yamamoto","year":"2017","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0385","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.yexcr.2015.04.004","article-title":"(\u2212)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer\u05f3 s disease model mice by upregulating neprilysin expression","volume":"334","author":"Chang","year":"2015","journal-title":"Experimental Cell Research"},{"issue":"11","key":"10.1016\/j.brainres.2025.149693_b0390","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.phymed.2010.03.008","article-title":"Epigallocatechin gallate inhibits beta amyloid oligomerization in Caenorhabditis elegans and affects the daf-2\/insulin-like signaling pathway","volume":"17","author":"Abbas","year":"2010","journal-title":"Phytomedicine"},{"issue":"198","key":"10.1016\/j.brainres.2025.149693_b0395","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.expneurol.2006.02.062","article-title":"Oral administration of green tea epigallocatechin-3-gallate (EGCG) reduces amyloid beta deposition in transgenic mouse model of Alzheimer's disease","volume":"2","author":"Li","year":"2006","journal-title":"Experimental Neurology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0400","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neurobiolaging.2007.05.012","article-title":"Epigallocatechin gallate (EGCG) suppresses \u03b2-amyloid-induced neurotoxicity through inhibiting c-Abl\/FE65 nuclear translocation and GSK3\u03b2 activation","volume":"30","author":"Lin","year":"2009","journal-title":"Neurobiology of Aging"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.02-0881fje","article-title":"Neuroprotection and neurorescue against A\u03b2 toxicity and PKC\u2010dependent release of non\u2010amyloidogenic soluble precursor protein by green tea polyphenol (\u2010)\u2010epigallocatechin\u20103\u2010gallate","volume":"17","author":"Levites","year":"2003","journal-title":"The FASEB Journal"},{"issue":"38","key":"10.1016\/j.brainres.2025.149693_b0410","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1523\/JNEUROSCI.1521-05.2005","article-title":"Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice","volume":"25","author":"Rezai-Zadeh","year":"2005","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.brainres.2025.149693_b0415","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2008.02.107","article-title":"Green tea epigallocatechin-3-gallate (EGCG) reduces \u03b2-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice","volume":"1214","author":"Rezai-Zadeh","year":"2008","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0420","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neulet.2010.01.026","article-title":"Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 mice","volume":"471","author":"Giunta","year":"2010","journal-title":"Neuroscience Letters"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0425","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jnr.10737","article-title":"ADAMs family members as amyloid precursor protein \u03b1\u2010secretases","volume":"74","author":"Allinson","year":"2003","journal-title":"Journal of Neuroscience Research"},{"issue":"41","key":"10.1016\/j.brainres.2025.149693_b0430","doi-asserted-by":"crossref","first-page":"37993","DOI":"10.1074\/jbc.M106434200","article-title":"Tumor necrosis factor-\u03b1-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)","volume":"276","author":"Garton","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.brainres.2025.149693_b0435","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10571-015-0232-4","article-title":"The distinct role of ADAM17 in APP proteolysis and microglial activation related to Alzheimer\u2019s disease","volume":"36","author":"Qian","year":"2016","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0440","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.2003.tb03207.x","article-title":"TACE\/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase","volume":"995","author":"Lee","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"24","key":"10.1016\/j.brainres.2025.149693_b0445","doi-asserted-by":"crossref","first-page":"16419","DOI":"10.1074\/jbc.M600617200","article-title":"ADAM10 activation is required for green tea (\u2013)-epigallocatechin-3-gallate-induced \u03b1-secretase cleavage of amyloid precursor protein","volume":"281","author":"Obregon","year":"2006","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/j.brainres.2025.149693_b0450","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1096\/fj.01-0007fje","article-title":"Regulation of the \u03b1\u2010secretase ADAM10 by its prodomain and proprotein convertases","volume":"15","author":"Anders","year":"2001","journal-title":"The FASEB Journal"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0455","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-4159.2006.03770.x","article-title":"Reduction of iron\u2010regulated amyloid precursor protein and \u03b2\u2010amyloid peptide by (\u2013)\u2010epigallocatechin\u20103\u2010gallate in cell cultures: implications for iron chelation in Alzheimer's disease","volume":"97","author":"Reznichenko","year":"2006","journal-title":"Journal of Neurochemistry"},{"issue":"19","key":"10.1016\/j.brainres.2025.149693_b0460","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1016\/j.febslet.2010.09.022","article-title":"EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP","volume":"584","author":"Fernandez","year":"2010","journal-title":"FEBS Letters"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0465","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2174\/1389450116666150825113655","article-title":"Potential role of (-)-epigallocatechin-3-gallate (EGCG) in the secondary prevention of Alzheimer disease","volume":"18","author":"Xicota","year":"2017","journal-title":"Current Drug Targets"},{"issue":"22","key":"10.1016\/j.brainres.2025.149693_b0470","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1016\/j.bmcl.2003.09.018","article-title":"Green tea catechins as a BACE1 (\u03b2-secretase) inhibitor","volume":"13","author":"Jeon","year":"2003","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"13","key":"10.1016\/j.brainres.2025.149693_b0475","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/WNR.0b013e32830b8ae1","article-title":"Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation","volume":"19","author":"Shimmyo","year":"2008","journal-title":"Neuroreport"},{"issue":"10","key":"10.1016\/j.brainres.2025.149693_b0480","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3945\/jn.109.109785","article-title":"Green tea (-)-epigallocatechin-3-gallate inhibits \u03b2-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-\u03baB pathways in mice","volume":"139","author":"Lee","year":"2009","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.brainres.2025.149693_b0485","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2008.10.012","article-title":"(\u2212)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency","volume":"1250","author":"Lee","year":"2009","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0490","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jnutbio.2012.06.011","article-title":"Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties","volume":"24","author":"Lee","year":"2013","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"11","key":"10.1016\/j.brainres.2025.149693_b0495","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1242\/jcs.113.11.1857","article-title":"Proteolytic processing and cell biological functions of the amyloid precursor protein","volume":"113","author":"De Strooper","year":"2000","journal-title":"Journal of Cell Science"},{"issue":"7","key":"10.1016\/j.brainres.2025.149693_b0500","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1073\/pnas.072033799","article-title":"A physiologic signaling role for the \u03b3-secretase-derived intracellular fragment of APP","volume":"99","author":"Leissring","year":"2002","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b0505","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1021\/jf001491+","article-title":"Metabolic fate of (\u2212)-[4-3H] epigallocatechin gallate in rats after oral administration","volume":"49","author":"Kohri","year":"2001","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"12","key":"10.1016\/j.brainres.2025.149693_b0510","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1271\/bbb.61.1981","article-title":"Dose-dependent incorporation of tea catechins,(-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma","volume":"61","author":"Nakagawa","year":"1997","journal-title":"Bioscience, Biotechnology, and Biochemistry"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b0515","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1271\/bbb.59.1558","article-title":"Absorption of (\u2013)-epigallocatechin gallate into the circulation system of rats","volume":"59","author":"Unno","year":"1995","journal-title":"Bioscience, Biotechnology, and Biochemistry"},{"issue":"10","key":"10.1016\/j.brainres.2025.149693_b0520","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/carcin\/19.10.1771","article-title":"Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue","volume":"19","author":"Suganuma","year":"1998","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b0525","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1021\/jf062816a","article-title":"Pharmacokinetics of (\u2212)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution","volume":"55","author":"Lin","year":"2007","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"11","key":"10.1016\/j.brainres.2025.149693_b0530","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/s41401-019-0243-7","article-title":"Increased BBB permeability contributes to EGCG-caused cognitive function improvement in natural aging rats: pharmacokinetic and distribution analyses","volume":"40","author":"Wei","year":"2019","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.brainres.2025.149693_b0535","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbrep.2016.12.012","article-title":"Blood brain barrier permeability of (\u2212)-epigallocatechin gallate, its proliferation-enhancing activity of human neuroblastoma SH-SY5Y cells, and its preventive effect on age-related cognitive dysfunction in mice","volume":"9","author":"Pervin","year":"2017","journal-title":"Biochemistry and Biophysics Reports"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b0540","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0024-3205(01)01438-2","article-title":"The green tea polyphenol (\u2212)-epigallocatechin gallate attenuates \u03b2-amyloid-induced neurotoxicity in cultured hippocampal neurons","volume":"70","author":"Choi","year":"2001","journal-title":"Life Sciences"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b0545","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s13205-022-03171-w","article-title":"Therapeutic effects of CoenzymeQ10, Biochanin A and Phloretin against arsenic and chromium induced oxidative stress in mouse (Mus musculus) brain","volume":"12","author":"Tripathi","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.brainres.2025.149693_b0550","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s12272-009-1609-z","article-title":"Neuroprotective effect of epigallocatechin-3-gallate against \u03b2-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity","volume":"32","author":"Kim","year":"2009","journal-title":"Archives of Pharmacal Research"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b0555","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/jn\/136.4.1043","article-title":"Long-term administration of green tea catechins improves spatial cognition learning ability in rats","volume":"136","author":"Haque","year":"2006","journal-title":"The Journal of Nutrition"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0560","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JAD-2011-101629","article-title":"Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction","volume":"26","author":"Dragicevic","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b0565","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jnutbio.2006.11.001","article-title":"Epigallocatechin-3-gallate suppresses NF-\u03baB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells","volume":"18","author":"Kim","year":"2007","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"10.1016\/j.brainres.2025.149693_b0570","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2015.11.048","article-title":"Epigallocatechin gallate attenuates amyloid \u03b2-induced inflammation and neurotoxicity in EOC 13.31 microglia","volume":"770","author":"Wei","year":"2016","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.brainres.2025.149693_b0575","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11064-016-2093-8","article-title":"Epigallocatechin gallate attenuates \u03b2-amyloid generation and oxidative stress involvement of PPAR\u03b3 in N2a\/APP695 cells","volume":"42","author":"Zhang","year":"2017","journal-title":"Neurochemical Research"},{"issue":"21","key":"10.1016\/j.brainres.2025.149693_b0580","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201801230","article-title":"Epigallocatechin\u20103\u2010gallate attenuates microglial inflammation and neurotoxicity by suppressing the activation of canonical and noncanonical inflammasome via TLR4\/NF\u2010\u03baB pathway","volume":"63","author":"Zhong","year":"2019","journal-title":"Molecular Nutrition & Food Research"},{"key":"10.1016\/j.brainres.2025.149693_b0585","doi-asserted-by":"crossref","unstructured":"S. Nan, P. Wang, Y. Zhang, and J. Fan, \u201cEpigallocatechin-3-gallate provides protection against Alzheimer\u2019s disease-induced learning and memory impairments in rats,\u201d Drug Design, Development and Therapy, pp. 2013-2024, 2021.","DOI":"10.2147\/DDDT.S289473"},{"key":"10.1016\/j.brainres.2025.149693_b0590","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2019.03.010","article-title":"Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)\/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe\/PS1dE9 Alzheimer's disease mice model","volume":"301","author":"Cano","year":"2019","journal-title":"Journal of Controlled Release"},{"issue":"10","key":"10.1016\/j.brainres.2025.149693_b0595","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3945\/jn.117.255034","article-title":"Epigallocatechin gallate has a neurorescue effect in a mouse model of Parkinson disease","volume":"147","author":"Xu","year":"2017","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.brainres.2025.149693_b0600","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12640-019-00143-6","article-title":"Protective effect of (\u2212) epigallocatechin-3-gallate on rotenone-induced parkinsonism-like symptoms in rats","volume":"37","author":"Tseng","year":"2020","journal-title":"Neurotoxicity Research"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b0605","first-page":"4883","article-title":"(-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease","volume":"17","author":"Zhou","year":"2018","journal-title":"Molecular Medicine Reports"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0610","first-page":"1","article-title":"Effects of green tea epigallocatechin-3-gallate (EGCG) on proteolipid protein (PLP) and oligodendrocyte transcription factor 1 (Olig1) expression in the cerebral cortex of cuprizone induced multiple sclerosis mice; a western blot study","volume":"2","author":"Semnani","year":"2016","journal-title":"Caspian Journal of Neurological Sciences"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0615","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5114\/fn.2017.70484","article-title":"Effects of green tea epigallocatechin-3-gallate on the proteolipid protein and oligodendrocyte transcription factor 1 messenger RNA gene expression in a mouse model of multiple sclerosis","volume":"55","author":"Semnani","year":"2017","journal-title":"Folia Neuropathologica"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0620","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2005.10.056","article-title":"The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice","volume":"395","author":"Koh","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.brainres.2025.149693_b0625","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s11064-006-9166-z","article-title":"Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"31","author":"Xu","year":"2006","journal-title":"Neurochemical Research"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035264","article-title":"Adult neurogenesis transiently generates oxidative stress","volume":"7","author":"Walton","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0635","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tips.2003.12.004","article-title":"\u03b2-Secretase inhibition for the treatment of Alzheimer's disease\u2013promise and challenge","volume":"25","author":"Citron","year":"2004","journal-title":"Trends in Pharmacological Sciences"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0640","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0301-0082(98)00055-0","article-title":"Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches","volume":"57","author":"Behl","year":"1999","journal-title":"Progress in Neurobiology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0645","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annual Review of Neuroscience"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0650","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","article-title":"Nitric oxide synthase and neuronal vulnerability in Parkinson's disease","volume":"72","author":"Hunot","year":"1996","journal-title":"Neuroscience"},{"issue":"21","key":"10.1016\/j.brainres.2025.149693_b0655","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1523\/JNEUROSCI.21-21-08447.2001","article-title":"Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease","volume":"21","author":"Le","year":"2001","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.brainres.2025.149693_b0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-8-44","article-title":"Expression of mutant alpha-synuclein modulates microglial phenotype in vitro","volume":"8","author":"Rojanathammanee","year":"2011","journal-title":"Journal of Neuroinflammation"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b0665","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.20315","article-title":"(\u2212)\u2010Epigallocatechin gallate inhibits lipopolysaccharide\u2010induced microglial activation and protects against inflammation\u2010mediated dopaminergic neuronal injury","volume":"78","author":"Li","year":"2004","journal-title":"Journal of Neuroscience Research"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0670","first-page":"473","article-title":"Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies","volume":"12","author":"Shafer","year":"1991","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0675","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0006-2952(01)00813-9","article-title":"Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-\u03baB) activation and cell death by tea extracts in neuronal cultures","volume":"63","author":"Levites","year":"2002","journal-title":"Biochemical Pharmacology"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0680","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1179\/135100002125000424","article-title":"Protective effects of green tea polyphenols and their major component,(\u2013)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells","volume":"7","author":"Nie","year":"2002","journal-title":"Redox Report"},{"key":"10.1016\/j.brainres.2025.149693_b0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-12-82","article-title":"Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1\/PGC-1\u03b1 signaling pathway","volume":"12","author":"Ye","year":"2012","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0690","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.2003.tb07476.x","article-title":"The 1\u2010methyl\u20104\u2010phenyl\u20101, 2, 3, 6\u2010tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease","volume":"991","author":"Przedborski","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b0695","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2001.00490.x","article-title":"Green tea polyphenol (\u2013)\u2010epigallocatechin\u20103\u2010gallate prevents N\u2010methyl\u20104\u2010phenyl\u20101, 2, 3, 6\u2010tetrahydropyridine\u2010induced dopaminergic neurodegeneration","volume":"78","author":"Levites","year":"2001","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0700","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0161-813X(02)00079-7","article-title":"Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson\u2019s disease in mice by tea phenolic epigallocatechin 3-gallate","volume":"23","author":"Choi","year":"2002","journal-title":"Neurotoxicology"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b0705","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.brainresbull.2009.08.013","article-title":"Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotection","volume":"80","author":"Leaver","year":"2009","journal-title":"Brain Research Bulletin"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0710","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1207\/S15327914NC3701_5","article-title":"Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols","volume":"37","author":"Kim","year":"2000","journal-title":"Nutrition and Cancer"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b0715","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jocn.2010.01.042","article-title":"Inhibition of inducible nitric oxide synthase expression and cell death by (\u2212)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"17","author":"Kim","year":"2010","journal-title":"Journal of Clinical Neuroscience"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b0720","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0024-3205(02)02347-0","article-title":"Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury","volume":"72","author":"Pan","year":"2003","journal-title":"Life Sciences"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0725","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/00498250701744641","article-title":"Molecular modelling study of the mechanism of high-potency inhibition of human catechol-O-methyltransferase by (\u2013)-epigallocatechin-3-O-gallate","volume":"38","author":"Zhu","year":"2008","journal-title":"Xenobiotica"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011951","article-title":"Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies","volume":"5","author":"Kang","year":"2010","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b0735","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jnnp.65.5.781","article-title":"Genetic and environmental risk factors for Parkinson\u2019s disease in a Chinese population","volume":"65","author":"Chan","year":"1998","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b0740","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/aje\/155.8.732","article-title":"Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake","volume":"155","author":"Checkoway","year":"2002","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0745","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.parkreldis.2008.02.011","article-title":"Smoking and tea consumption delay onset of Parkinson's disease","volume":"15","author":"Kandinov","year":"2009","journal-title":"Parkinsonism & Related Disorders"},{"issue":"22","key":"10.1016\/j.brainres.2025.149693_b0750","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b0755","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/WCO.0b013e328356d328","article-title":"Amyotrophic lateral sclerosis","volume":"25","author":"Ludolph","year":"2012","journal-title":"Current Opinion in Neurology"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b0760","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.0b013e3182635720","article-title":"Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS","volume":"79","author":"Quinn","year":"2012","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.brainres.2025.149693_b0765","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1212\/WNL.0b013e31826c1aa1","article-title":"The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALS","volume":"79","author":"Raaphorst","year":"2012","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b0770","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1212\/WNL.57.9.1571","article-title":"Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS","volume":"57","author":"Ellis","year":"2001","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.brainres.2025.149693_b0775","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0b013e31826e25df","article-title":"SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"79","author":"Rubino","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2025.149693_b0780","doi-asserted-by":"crossref","unstructured":"S. H. Appel and L. P. Rowland, \u201cAmyotrophic lateral sclerosis, frontotemporal lobar dementia, and p62: a functional convergence?,\u201d vol. 79, ed: AAN Enterprises, 2012, pp. 1526-1527.","DOI":"10.1212\/WNL.0b013e31826e26ec"},{"issue":"11","key":"10.1016\/j.brainres.2025.149693_b0785","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/brain\/123.11.2289","article-title":"Extramotor involvement in ALS: PET studies with the GABAA ligand [11C] flumazenil","volume":"123","author":"Lloyd","year":"2000","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.brainres.2025.149693_b0790","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.57.7.1282","article-title":"Immune reactivity in a mouse model of familial ALS correlates with disease progression","volume":"57","author":"Alexianu","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0795","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.10805","article-title":"Presence of dendritic cells, MCP\u20101, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue","volume":"55","author":"Henkel","year":"2004","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b0800","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.10374","article-title":"Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS","volume":"52","author":"Drachman","year":"2002","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"13","key":"10.1016\/j.brainres.2025.149693_b0805","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.febslet.2010.05.011","article-title":"Epigallocatechin\u20103\u2010gallate protects motor neurons and regulates glutamate level","volume":"584","author":"Yu","year":"2010","journal-title":"FEBS Letters"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b0810","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.freeradbiomed.2009.06.001","article-title":"Green tea EGCG suppresses T cell proliferation through impairment of IL-2\/IL-2 receptor signaling","volume":"47","author":"Wu","year":"2009","journal-title":"Free Radical Biology and Medicine"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b0815","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archneurol.2011.2450","article-title":"Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study","volume":"69","author":"Sinnecker","year":"2012","journal-title":"Archives of Neurology"},{"issue":"11","key":"10.1016\/j.brainres.2025.149693_b0820","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b0825","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.clineuro.2010.04.014","article-title":"Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients","volume":"112","author":"Bock","year":"2010","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"7","key":"10.1016\/j.brainres.2025.149693_b0830","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1177\/1352458510365156","article-title":"Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study","volume":"16","author":"Bock","year":"2010","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.brainres.2025.149693_b0835","first-page":"1502","article-title":"Coles","volume":"372","author":"Compston","year":"2008","journal-title":"Multiple Sclerosis. Lancet"},{"key":"10.1016\/j.brainres.2025.149693_b0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1878-5085-3-9","article-title":"Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy","volume":"3","author":"Borisow","year":"2012","journal-title":"EPMA Journal"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0845","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014606","article-title":"The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions","volume":"6","author":"Handel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2025.149693_b0850","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s00415-009-5441-7","article-title":"Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management","volume":"257","author":"Simmons","year":"2010","journal-title":"Journal of Neurology"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b0855","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/1352458508093615","article-title":"Smoking worsens the prognosis in multiple sclerosis","volume":"14","author":"Sundstr\u00f6m","year":"2008","journal-title":"Multiple Sclerosis Journal"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b0860","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/1352458506073501","article-title":"Smoking is a risk factor for multiple sclerosis: a metanalysis","volume":"13","author":"Hawkes","year":"2007","journal-title":"Multiple Sclerosis Journal"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0865","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.20913","article-title":"How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis","volume":"60","author":"Steinman","year":"2006","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.brainres.2025.149693_b0870","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00415-008-6003-0","article-title":"Animal models of multiple sclerosis for the development and validation of novel therapies\u2013potential and limitations","volume":"255","author":"Mix","year":"2008","journal-title":"Journal of Neurology"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b0875","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1177\/1352458510379612","article-title":"Improving the translational hit of experimental treatments in multiple sclerosis","volume":"16","author":"Vesterinen","year":"2010","journal-title":"Multiple Sclerosis Journal"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b0880","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.4049\/jimmunol.173.9.5794","article-title":"Green tea epigallocatechin-3-gallate mediates T cellular NF-\u03baB inhibition and exerts neuroprotection in autoimmune encephalomyelitis","volume":"173","author":"Aktas","year":"2004","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.brainres.2025.149693_b0885","first-page":"S25","article-title":"The mechanism of action of glatiramer acetate treatment in multiple sclerosis","volume":"vol. 74, no. 1_supplement_1","author":"Racke","year":"2010","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.brainres.2025.149693_b0890","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archneurol.2010.158","article-title":"Translational research in neurology and neuroscience 2010: multiple sclerosis","volume":"67","author":"St\u00fcve","year":"2010","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b0895","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/1352458512469695","article-title":"Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome","volume":"19","author":"Comi","year":"2013","journal-title":"Multiple Sclerosis Journal"},{"issue":"10","key":"10.1016\/j.brainres.2025.149693_b0900","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025456","article-title":"Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation","volume":"6","author":"Herges","year":"2011","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0905","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajpath.2011.09.007","article-title":"Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets","volume":"180","author":"Wang","year":"2012","journal-title":"The American Journal of Pathology"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b0910","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1177\/1352458507077175","article-title":"Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors","volume":"13","author":"Trojan","year":"2007","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.brainres.2025.149693_b0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13167-011-0136-4","article-title":"Exercise in multiple sclerosis\u2013an integral component of disease management","volume":"3","author":"D\u00f6ring","year":"2012","journal-title":"Epma Journal"},{"issue":"7","key":"10.1016\/j.brainres.2025.149693_b0920","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/1352458509105383","article-title":"Fatigued patients with multiple sclerosis have impaired central muscle activation","volume":"15","author":"Andreasen","year":"2009","journal-title":"Multiple Sclerosis Journal"},{"issue":"7","key":"10.1016\/j.brainres.2025.149693_b0925","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/ejcn.2010.47","article-title":"Epigallocatechin-3-gallate and postprandial fat oxidation in overweight\/obese male volunteers: a pilot study","volume":"64","author":"Thielecke","year":"2010","journal-title":"European Journal of Clinical Nutrition"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0930","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiological Reviews"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0935","doi-asserted-by":"crossref","first-page":"e4962","DOI":"10.1371\/journal.pone.0004962","article-title":"Neuroendocrine disturbances in Huntington's disease","volume":"4","author":"Saleh","year":"2009","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.brainres.2025.149693_b0940","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.fct.2009.07.011","article-title":"Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism","volume":"47","author":"Kumar","year":"2009","journal-title":"Food and Chemical Toxicology"},{"issue":"9624","key":"10.1016\/j.brainres.2025.149693_b0945","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(08)60694-7","article-title":"andS. M. Davis,\u201c\u201d Stroke","volume":"371","author":"Donnan","year":"2008","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b0950","article-title":"Green tea extract ameliorates learning and memory deficits in ischemic rats via its active component polyphenol epigallocatechin\u20103\u2010gallate by modulation of oxidative stress and neuroinflammation","volume":"2012","author":"Wu","year":"2012","journal-title":"Evidence\u2010based Complementary and Alternative Medicine"},{"issue":"41","key":"10.1016\/j.brainres.2025.149693_b0955","doi-asserted-by":"crossref","first-page":"34694","DOI":"10.1074\/jbc.M112.356899","article-title":"Green tea polyphenols precondition against cell death induced by oxygen-glucose deprivation via stimulation of laminin receptor, generation of reactive oxygen species, and activation of protein kinase C\u220a","volume":"287","author":"Gundimeda","year":"2012","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0960","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jnr.21847","article-title":"Green tea polyphenol (\u2013)\u2010epigallocatechin gallate reduces neuronal cell damage and up\u2010regulation of MMP\u20109 activity in hippocampal CA1 and CA2 areas following transient global cerebral ischemia","volume":"87","author":"Park","year":"2009","journal-title":"Journal of Neuroscience Research"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0965","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01159-9","article-title":"Protective effects of the green tea polyphenol (\u2212)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils","volume":"287","author":"Lee","year":"2000","journal-title":"Neuroscience Letters"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b0970","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0361-9230(03)00139-4","article-title":"Effects of delayed administration of (\u2212)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils","volume":"61","author":"Lee","year":"2003","journal-title":"Brain Research Bulletin"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2025.149693_b0975","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainres.2004.05.079","article-title":"Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats","volume":"1019","author":"Choi","year":"2004","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0980","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0006-8993(02)03564-3","article-title":"(\u2212)-Epigallocatechin gallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant","volume":"956","author":"Nagai","year":"2002","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b0985","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neulet.2005.03.018","article-title":"(\u2212)-Epigallocatechin gallate as an intervention for the acute treatment of cerebral ischemia","volume":"382","author":"Rahman","year":"2005","journal-title":"Neuroscience Letters"},{"issue":"11","key":"10.1016\/j.brainres.2025.149693_b0990","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jnutbio.2009.08.009","article-title":"Green tea polyphenol (\u2212)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia","volume":"21","author":"Park","year":"2010","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b0995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.04-2806fje","article-title":"Neuroprotective effects of (\u2212)\u2010epigallocatechin gallate after hypoxia\u2010ischemia\u2010induced brain damage: novel mechanisms of action","volume":"19","author":"Sutherland","year":"2005","journal-title":"The FASEB Journal"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1000","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2003.11.056","article-title":"Green tea polyphenol (\u2212)-epigallocatechin gallate attenuates the neuronal NADPH-d\/nNOS expression in the nodose ganglion of acute hypoxic rats","volume":"999","author":"Wei","year":"2004","journal-title":"Brain Research"},{"key":"10.1016\/j.brainres.2025.149693_b1005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10571-011-9758-2","article-title":"EGCG ameliorates the suppression of long-term potentiation induced by ischemia at the Schaffer collateral-CA1 synapse in the rat","volume":"32","author":"Ding","year":"2012","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b1010","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/STROKEAHA.108.538470","article-title":"Green and black tea consumption and risk of stroke: a meta-analysis","volume":"40","author":"Arab","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2025.149693_b1015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.phrs.2018.11.001","article-title":"Molecular pharmacology of inflammation: Medicinal plants as anti-inflammatory agents","volume":"139","author":"Tasneem","year":"2019","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.brainres.2025.149693_b1020","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.30.1_supplement.1174.11","article-title":"Neurorescue effect of EGCG in an animal model of Parkinson's disease","volume":"30","author":"Xu","year":"2016","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.brainres.2025.149693_b1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2018.11.028","article-title":"(-)-Epigallocatechin-3-gallate suppresses cigarette smoke-induced inflammation in human cardiomyocytes via ROS-mediated MAPK and NF-\u03baB pathways","volume":"58","author":"Liang","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.brainres.2025.149693_b1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118260","article-title":"Epigallocatechin gallate diminishes cigarette smoke-induced oxidative stress, lipid peroxidation, and inflammation in human bronchial epithelial cells","volume":"259","author":"Lakshmi","year":"2020","journal-title":"Life Sciences"},{"key":"10.1016\/j.brainres.2025.149693_b1035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2021.02.132","article-title":"Epigallocatechin-3-gallate exhibits immunomodulatory effects in human primary T cells","volume":"550","author":"Huang","year":"2021","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.brainres.2025.149693_b1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106872","article-title":"Blockade of RANKL\/RANK signaling pathway by epigallocatechin gallate alleviates mast cell-mediated inflammatory reactions","volume":"88","author":"Kim","year":"2020","journal-title":"International Immunopharmacology"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b1045","first-page":"317","article-title":"Epigallocatechin 3\u2010gallate attenuates arthritis by regulating Nrf2, HO\u20101, and cytokine levels in an experimental arthritis model","volume":"67","author":"Karatas","year":"2020","journal-title":"Biotechnology and Applied Biochemistry"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b1050","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.3390\/ijms22063037","article-title":"Epigallocatechin-3-gallate-loaded liposomes favor anti-inflammation of microglia cells and promote neuroprotection","volume":"22","author":"Cheng","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b1055","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/1531-8257(199907)14:4<612::AID-MDS1010>3.0.CO;2-6","article-title":"Apomorphine protects against MPTP\u2010induced neurotoxicity in mice","volume":"14","author":"Gr\u00fcnblatt","year":"1999","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1060","first-page":"146","article-title":"Effects of R\u2010and S\u2010apomorphine on MPTP\u2010induced nigro\u2010striatal dopamine neuronal loss","volume":"77","author":"Gr\u00fcnblatt","year":"2001","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b1065","first-page":"210","article-title":"\u201cStudies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes,\u201d Biochimica et Biophysica Acta (BBA)-Lipids and Lipid","volume":"1304","author":"Guo","year":"1996","journal-title":"Metabolism"},{"issue":"34","key":"10.1016\/j.brainres.2025.149693_b1070","doi-asserted-by":"crossref","first-page":"30574","DOI":"10.1074\/jbc.M202832200","article-title":"Involvement of protein kinase C activation and cell survival\/cell cycle genes in green tea polyphenol (\u2212)-epigallocatechin 3-gallate neuroprotective action","volume":"277","author":"Levites","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b1075","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1124\/dmd.31.5.572","article-title":"Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (\u2212)-epigallocatechin gallate","volume":"31","author":"Lu","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.brainres.2025.149693_b1080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00003088-200241040-00003","article-title":"Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson\u2019s disease","volume":"41","author":"Deleu","year":"2002","journal-title":"Clinical Pharmacokinetics"},{"issue":"9278","key":"10.1016\/j.brainres.2025.149693_b1085","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0140-6736(01)05522-2","article-title":"New genes reveal major role for iron in neurodegeneration","volume":"358","author":"Senior","year":"2001","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0014-2999(90)91245-7","article-title":"The implications of increased iron in parkinsonian substantia nigra and its high affinity binding to melanin for dopamine neuron degeneration","volume":"183","author":"Riederer","year":"1990","journal-title":"European Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b1095","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1046\/j.1471-4159.2001.00186.x","article-title":"Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes","volume":"76","author":"Zecca","year":"2001","journal-title":"Journal of Neurochemistry"},{"issue":"23","key":"10.1016\/j.brainres.2025.149693_b1100","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1016\/0006-2952(89)90512-1","article-title":"6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation","volume":"38","author":"Monteiro","year":"1989","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1471-4159.1994.62010134.x","article-title":"Increased iron in the substantia nigra compacta of the MPTP\u2010lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis","volume":"62","author":"Temlett","year":"1994","journal-title":"Journal of Neurochemistry"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b1110","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jnutbio.2007.08.008","article-title":"Green tea catechins prevent cognitive deficits caused by A\u03b21\u201340 in rats","volume":"19","author":"Haque","year":"2008","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"5516","key":"10.1016\/j.brainres.2025.149693_b1115","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.brainres.2025.149693_b1120","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s11064-006-9268-7","article-title":"Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress","volume":"32","author":"Siddiq","year":"2007","journal-title":"Neurochemical Research"},{"issue":"50","key":"10.1016\/j.brainres.2025.149693_b1125","doi-asserted-by":"crossref","first-page":"41732","DOI":"10.1074\/jbc.M504963200","article-title":"Hypoxia-inducible factor prolyl 4-hydroxylase inhibition: a target for neuroprotection in the central nervous system","volume":"280","author":"Siddiq","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"22","key":"10.1016\/j.brainres.2025.149693_b1130","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1523\/JNEUROSCI.19-22-09821.1999","volume":"19","author":"Zaman","year":"1999","journal-title":"Journal of Neuroscience"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b1135","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbrc.2005.06.114","article-title":"Epigallocatechin gallate inhibits HIF-1\u03b1 degradation in prostate cancer cells","volume":"334","author":"Thomas","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"12","key":"10.1016\/j.brainres.2025.149693_b1140","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1021\/np040140c","article-title":"Hypoxia-inducible factor-1 activation by (\u2212)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts","volume":"67","author":"Zhou","year":"2004","journal-title":"Journal of Natural Products"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b1145","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.abb.2008.01.004","article-title":"The application of proteomics for studying the neurorescue activity of the polyphenol (\u2212)-epigallocatechin-3-gallate","volume":"476","author":"Weinreb","year":"2008","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b1150","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.freeradbiomed.2007.05.011","article-title":"A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant\u2013iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate","volume":"43","author":"Weinreb","year":"2007","journal-title":"Free Radical Biology and Medicine"},{"issue":"13","key":"10.1016\/j.brainres.2025.149693_b1155","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1021\/bi047433p","article-title":"Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein","volume":"44","author":"Palermo","year":"2005","journal-title":"Biochemistry"},{"issue":"23","key":"10.1016\/j.brainres.2025.149693_b1160","doi-asserted-by":"crossref","first-page":"11094","DOI":"10.1158\/0008-5472.CAN-05-1877","article-title":"Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors","volume":"65","author":"Ibrahim","year":"2005","journal-title":"Cancer Research"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b1165","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1074\/jbc.274.8.5047","article-title":"Hypoxia post-translationally activates iron-regulatory protein 2","volume":"274","author":"Hanson","year":"1999","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.brainres.2025.149693_b1170","first-page":"367","article-title":"Regulation of the iron regulatory proteins by reactive nitrogen and oxygen species","volume":"vol. 7, no. 4-5-6","author":"Hanson","year":"1999","journal-title":"Gene Expression"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2025.149693_b1175","first-page":"79","article-title":"\u201cThe pathway for IRP2 degradation involving 2-oxoglutarate-dependent oxygenase (s) does not require the E3 ubiquitin ligase activity of pVHL,\u201d Biochimica et Biophysica Acta (BBA)-Molecular","volume":"1743","author":"Wang","year":"2005","journal-title":"Cell Research"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b1180","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0891-5849(96)00237-7","article-title":"Scavenging effects of tea catechins and their derivatives on 1, 1-diphenyl-2-picrylhydrazyl radical","volume":"21","author":"Nanjo","year":"1996","journal-title":"Free Radical Biology and Medicine"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b1185","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1271\/bbb.63.1621","article-title":"Radical scavenging activity of tea catechins and their related compounds","volume":"63","author":"Nanjo","year":"1999","journal-title":"Bioscience, Biotechnology, and Biochemistry"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1190","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/bbrc.1997.6254","article-title":"Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols","volume":"232","author":"Pannala","year":"1997","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"10.1016\/j.brainres.2025.149693_b1195","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1021\/jf021066b","article-title":"Factors affecting the levels of tea polyphenols and caffeine in tea leaves","volume":"51","author":"Lin","year":"2003","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-2952(93)90371-3","article-title":"Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures","volume":"45","author":"Morel","year":"1993","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-4165(98)00168-8","article-title":"ESR study on the structure\u2013antioxidant activity relationship of tea catechins and their epimers","volume":"1427","author":"Guo","year":"1999","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2003.08.007","article-title":"Epigallocatechin 3-gallate attenuates neuronal damage induced by 3-hydroxykynurenine","volume":"195","author":"Jeong","year":"2004","journal-title":"Toxicology"},{"issue":"1\u20133","key":"10.1016\/j.brainres.2025.149693_b1215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0300-483X(02)00512-7","article-title":"Inhibitory activity of epigallocatechin gallate (EGCg) in paraquat-induced microsomal lipid peroxidation\u2014a mechanism of protective effects of EGCg against paraquat toxicity","volume":"183","author":"Higuchi","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.brainres.2025.149693_b1220","first-page":"143","article-title":"Protective effects of green tea and epigallocatechin gallate against paraquat toxicity in mice","volume":"12","author":"Yonemitsu","year":"1999","journal-title":"Jpn. J. Toxicol.,"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b1225","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0003-2670(01)84703-6","article-title":"Stability of flavonoid complexes of copper (II) and flavonoid antioxidant activity","volume":"85","author":"Thompson","year":"1976","journal-title":"Analytica Chimica Acta"},{"key":"10.1016\/j.brainres.2025.149693_b1230","doi-asserted-by":"crossref","unstructured":"S. Van Acker, D. van den Berg, and M. Tromp, \u201cStructural aspects of antioxidant activity of flavanoids,\u201d 1996.","DOI":"10.1016\/0891-5849(95)02047-0"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b1235","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0006-2952(97)00155-X","article-title":"Protective effects of tea polyphenols against oxidative damage to red blood cells","volume":"54","author":"Grinberg","year":"1997","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b1240","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","article-title":"Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains","volume":"52","author":"Riederer","year":"1989","journal-title":"Journal of Neurochemistry"},{"issue":"23","key":"10.1016\/j.brainres.2025.149693_b1245","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease","volume":"15","author":"Gong","year":"2008","journal-title":"Current Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","article-title":"Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration","volume":"25","author":"Wang","year":"2007","journal-title":"European Journal of Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2025.149693_b1255","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-\u03b1 (TNF-\u03b1) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neuroscience Letters"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b1260","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-0773.1996.tb00270.x","article-title":"The Enhancing Effect of Tumour Necrosis Factor\u2010\u03b1 on Oxidative Stress in Endotoxemia","volume":"79","author":"Sakaguchi","year":"1996","journal-title":"Pharmacology & Toxicology"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b1265","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/mol.52.3.465","article-title":"(\u2212)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-\u03baB","volume":"52","author":"Lin","year":"1997","journal-title":"Molecular Pharmacology"},{"issue":"14","key":"10.1016\/j.brainres.2025.149693_b1270","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","article-title":"Nuclear translocation of NF-\u03baB is increased in dopaminergic neurons of patients with Parkinson disease","volume":"94","author":"Hunot","year":"1997","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.brainres.2025.149693_b1275","first-page":"S35","article-title":"Neuroprotection by black and green tea extracts involves inhibition of translocation and activity of NfkappaB in neuronal cells","volume":"55","author":"Mandel","year":"2000","journal-title":"Neurosci Lett Suppl"},{"issue":"12","key":"10.1016\/j.brainres.2025.149693_b1280","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1093\/jn\/128.12.2334","article-title":"Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model","volume":"128","author":"Yang","year":"1998","journal-title":"The Journal of Nutrition"},{"issue":"2\u20133","key":"10.1016\/j.brainres.2025.149693_b1285","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0014-2999(98)00953-4","article-title":"Theaflavin-3, 3\u2032-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-\u03baB in macrophages","volume":"367","author":"Lin","year":"1999","journal-title":"European Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b1290","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0006-2952(99)00335-4","article-title":"Suppression of lipopolysaccharide-induced nuclear factor-\u03baB activity by theaflavin-3, 3\u2032-digallate from black tea and other polyphenols through down-regulation of I\u03baB kinase activity in macrophages","volume":"59","author":"Pan","year":"2000","journal-title":"Biochemical Pharmacology"},{"issue":"47","key":"10.1016\/j.brainres.2025.149693_b1295","doi-asserted-by":"crossref","first-page":"45518","DOI":"10.1074\/jbc.M207435200","article-title":"An iron-responsive element type II in the 5\u2032-untranslated region of the Alzheimer's amyloid precursor protein transcript","volume":"277","author":"Rogers","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b1300","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neures.2008.11.006","article-title":"Amyloid-\u03b225\u201335 impairs memory and increases NO in the temporal cortex of rats","volume":"63","author":"Limon","year":"2009","journal-title":"Neuroscience Research"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b1305","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.mp.4001937","article-title":"The 5\u2032-untranslated region of Parkinson's disease \u03b1-synuclein messengerRNA contains a predicted iron responsive element","volume":"12","author":"Friedlich","year":"2007","journal-title":"Molecular Psychiatry"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b1310","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12263-007-0056-z","article-title":"The interactions of flavonoids within neuronal signalling pathways","volume":"2","author":"Spencer","year":"2007","journal-title":"Genes & Nutrition"},{"issue":"7","key":"10.1016\/j.brainres.2025.149693_b1315","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.freeradbiomed.2004.01.001","article-title":"Flavonoids: antioxidants or signalling molecules?","volume":"36","author":"Williams","year":"2004","journal-title":"Free Radical Biology and Medicine"},{"issue":"7","key":"10.1016\/j.brainres.2025.149693_b1320","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1523\/JNEUROSCI.19-07-02455.1999","article-title":"The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons","volume":"19","author":"Singer","year":"1999","journal-title":"Journal of Neuroscience"},{"issue":"5240","key":"10.1016\/j.brainres.2025.149693_b1325","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","article-title":"Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis","volume":"270","author":"Xia","year":"1995","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b1330","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1046\/j.1471-4159.2003.01631.x","article-title":"Estrogen activates protein kinase C in neurons: role in neuroprotection","volume":"84","author":"Cordey","year":"2003","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b1335","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1471-4159.2005.03085.x","article-title":"Green tea polyphenol (\u2013)\u2010epigallocatechin\u20103\u2010gallate induces neurorescue of long\u2010term serum\u2010deprived PC12 cells and promotes neurite outgrowth","volume":"93","author":"Reznichenko","year":"2005","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b1340","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0959-4388(00)00092-1","article-title":"Neurotrophin signal transduction in the nervous system","volume":"10","author":"Kaplan","year":"2000","journal-title":"Current Opinion in Neurobiology"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2025.149693_b1345","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molbrainres.2003.07.003","article-title":"Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase\/Akt and glycogen synthase kinase-3","volume":"118","author":"Koh","year":"2003","journal-title":"Molecular Brain Research"},{"key":"10.1016\/j.brainres.2025.149693_b1350","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF03033171","article-title":"Green tea polyphenol (\u2212)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal","volume":"5","author":"Mandel","year":"2003","journal-title":"Neurotoxicity Research"},{"key":"10.1016\/j.brainres.2025.149693_b1355","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/BF02975249","article-title":"Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death","volume":"23","author":"Chen","year":"2000","journal-title":"Archives of Pharmacal Research"},{"key":"10.1016\/j.brainres.2025.149693_b1360","doi-asserted-by":"crossref","unstructured":"O. Ed, \u201cAntioxidants and oxidants regulated signal transduction pathways,\u201d Biochem Pharmacol., vol. 64, pp. 765-770, 2002.","DOI":"10.1016\/S0006-2952(02)01137-1"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b1365","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3940(00)01229-5","article-title":"Neuroprotection by MAPK\/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons","volume":"288","author":"Satoh","year":"2000","journal-title":"Neuroscience Letters"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b1370","doi-asserted-by":"crossref","first-page":"L429","DOI":"10.1152\/ajplung.2000.279.3.L429","article-title":"Protein kinase C isozymes and the regulation of diverse cell responses","volume":"279","author":"Dempsey","year":"2000","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b1375","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1523\/JNEUROSCI.21-09-02929.2001","article-title":"How protein kinase C activation protects nerve cells from oxidative stress-induced cell death","volume":"21","author":"Maher","year":"2001","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b1380","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1046\/j.1471-4159.1994.63031095.x","article-title":"Regional alterations of protein kinase C activity following transient cerebral ischemia: effects of intraischemic brain temperature modulation","volume":"63","author":"Busto","year":"1994","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b1385","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1471-4159.1993.tb13623.x","article-title":"Time course of the translocation and inhibition of protein kinase C during complete cerebral ischemia in the rat","volume":"61","author":"Cardell","year":"1993","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b1390","first-page":"823","article-title":"Overexpression of Protein Kinase C Isoform but not \u03b4 in Human Interleukin-3\u2013Dependent Cells Suppresses Apoptosis and Induces bcl-2 Expression","volume":"91","author":"Gubina","year":"1998","journal-title":"Blood, the Journal of the American Society of Hematology"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b1395","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(97)00894-X","article-title":"Specific role for protein kinase C\u03b1 in the constitutive and regulated secretion of amyloid precursor protein in human skin fibroblasts","volume":"240","author":"Benussi","year":"1998","journal-title":"Neuroscience Letters"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1400","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1471-4159.1996.67010317.x","article-title":"Ca2+\u2010Dependent and Ca2+\u2010Independent Protein Kinase C Changes in the Brains of Patients with Alzheimer's Disease","volume":"67","author":"Matsushima","year":"1996","journal-title":"Journal of Neurochemistry"},{"issue":"39","key":"10.1016\/j.brainres.2025.149693_b1405","doi-asserted-by":"crossref","first-page":"25436","DOI":"10.1074\/jbc.273.39.25436","article-title":"A functional role for mitochondrial protein kinase C\u03b1 in Bcl2 phosphorylation and suppression of apoptosis","volume":"273","author":"Ruvolo","year":"1998","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1410","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1749-6632.2003.tb07544.x","article-title":"Gene and protein expression profiles of anti\u2010and pro\u2010apoptotic actions of dopamine, R\u2010apomorphine, green tea polyphenol (\u2212)\u2010epigallocatechine\u20103\u2010gallate, and melatonin","volume":"993","author":"Weinreb","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b1415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.02-0712fje","article-title":"cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells","volume":"17","author":"Weinreb","year":"2003","journal-title":"The FASEB Journal"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b1420","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1471-4159.2006.04265.x","article-title":"Green tea polyphenol (\u2013)\u2010epigallocatechin\u20103\u2010gallate promotes the rapid protein kinase C\u2010and proteasome\u2010mediated degradation of Bad: implications for neuroprotection","volume":"100","author":"Kalfon","year":"2007","journal-title":"Journal of Neurochemistry"},{"issue":"17","key":"10.1016\/j.brainres.2025.149693_b1425","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1111\/j.0014-2956.2004.04242.x","article-title":"Phospholipase C, protein kinase C, Ca2+\/calmodulin\u2010dependent protein kinase II, and redox state are involved in epigallocatechin gallate\u2010induced phospholipase D activation in human astroglioma cells","volume":"271","author":"Kim","year":"2004","journal-title":"European Journal of Biochemistry"},{"issue":"13","key":"10.1016\/j.brainres.2025.149693_b1430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.02-0914fje","article-title":"Dual mechanisms of green tea extract\u2010induced cell survival in human epidermal keratinocytes","volume":"17","author":"Chung","year":"2003","journal-title":"The FASEB Journal"},{"issue":"13","key":"10.1016\/j.brainres.2025.149693_b1435","doi-asserted-by":"crossref","first-page":"12755","DOI":"10.1074\/jbc.M312333200","article-title":"Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway: evidence for direct inhibition of ERK1\/2 and AKT kinases","volume":"279","author":"Sah","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b1440","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/10715769609149066","article-title":"Commentary: vitamin C: antioxidant or pro-oxidant in vivo?","volume":"25","author":"Halliwell","year":"1996","journal-title":"Free Radical Research"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b1445","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/mds.870130409","article-title":"Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6\u2010hydroxydopamine","volume":"13","author":"Gassen","year":"1998","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b1450","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1471-4159.2006.04434.x","article-title":"(\u2010) Epicatechin stimulates ERK\u2010dependent cyclic AMP response element activity and up\u2010regulates GluR2 in cortical neurons","volume":"101","author":"Schroeter","year":"2007","journal-title":"Journal of Neurochemistry"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b1455","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nrn1197","article-title":"14-3-3 proteins in the nervous system","volume":"4","author":"Berg","year":"2003","journal-title":"Nature Reviews Neuroscience"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b1460","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1046\/j.1471-4159.2003.02291.x","article-title":"Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (\u2010)\u2010epigallocatechin\u20103\u2010gallate: implications for neurodegenerative diseases","volume":"88","author":"Mandel","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.brainres.2025.149693_b1465","series-title":"Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer\u2019s disease and Down syndrome","author":"Fountoulakis","year":"1999"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b1470","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9440(10)63322-6","article-title":"The 14-3-3 protein \u03b5 isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes","volume":"165","author":"Satoh","year":"2004","journal-title":"The American Journal of Pathology"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b1475","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1021\/tx960130e","article-title":"\u03b2-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease","volume":"10","author":"Butterfield","year":"1997","journal-title":"Chemical Research in Toxicology"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b1480","first-page":"325","article-title":"In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42)","volume":"20","author":"Yatin","year":"1999","journal-title":"Neurobiology of Aging"},{"issue":"2\u20133","key":"10.1016\/j.brainres.2025.149693_b1485","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/jsbi.2000.4274","article-title":"Alzheimer's amyloid \u03b2-peptide-associated free radical oxidative stress and neurotoxicity","volume":"130","author":"Varadarajan","year":"2000","journal-title":"Journal of Structural Biology"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b1490","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/nbdi.2002.0515","article-title":"Oxidative stress increases expression and activity of BACE in NT2 neurons","volume":"10","author":"Tamagno","year":"2002","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1495","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/ph12010041","article-title":"BACE-1 and \u03b3-secretase as therapeutic targets for Alzheimer\u2019s disease","volume":"12","author":"Maia","year":"2019","journal-title":"Pharmaceuticals"},{"issue":"52","key":"10.1016\/j.brainres.2025.149693_b1500","doi-asserted-by":"crossref","first-page":"32508","DOI":"10.1039\/C7RA03752J","article-title":"(\u2212)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of \u03b1-synuclein, and protects PC12 cells against \u03b1-synuclein-induced toxicity","volume":"7","author":"Zhao","year":"2017","journal-title":"RSC Advances"},{"issue":"16","key":"10.1016\/j.brainres.2025.149693_b1505","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3390\/molecules24162940","article-title":"Complex of EGCG with Cu (II) suppresses amyloid aggregation and Cu (II)-induced cytotoxicity of \u03b1-synuclein","volume":"24","author":"Teng","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1510","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cellbi.2007.08.007","article-title":"Neuroprotective effects of (\u2212)\u2010epigallocatechin\u20103\u2010gallate (EGCG) on paraquat\u2010induced apoptosis in PC12 cells","volume":"32","author":"Hou","year":"2008","journal-title":"Cell Biology International"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b1515","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3233\/JAD-2009-1048","article-title":"(-)-Epigallocatechin-3-gallate protects SH-SY5Y cells against 6-OHDA-induced cell death through STAT3 activation","volume":"17","author":"Wang","year":"2009","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.brainres.2025.149693_b1520","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00702-009-0284-z","article-title":"Effects of epigallocatechin gallate on rotenone-injured murine brain cultures","volume":"117","author":"Moldzio","year":"2010","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.brainres.2025.149693_b1525","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153316","article-title":"The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review","volume":"79","author":"Zhang","year":"2020","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1530","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1248\/bpb.32.55","article-title":"Neuroprotective effects of (\u2212)-epigallocatechin-3-gallate on aging mice induced by D-galactose","volume":"32","author":"He","year":"2009","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.1016\/j.brainres.2025.149693_b1535","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbr.2012.08.039","article-title":"Green tea (\u2212) epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia","volume":"236","author":"Biasibetti","year":"2013","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.brainres.2025.149693_b1540","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fnagi.2018.00244","article-title":"EGCG nanoparticles attenuate aluminum chloride induced neurobehavioral deficits, beta amyloid and tau pathology in a rat model of Alzheimer\u2019s disease","volume":"10","author":"Singh","year":"2018","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.brainres.2025.149693_b1545","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.arr.2013.10.002","article-title":"The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model","volume":"13","author":"Cheng","year":"2014","journal-title":"Ageing Research Reviews"},{"issue":"10","key":"10.1016\/j.brainres.2025.149693_b1550","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/WNR.0000000000000803","article-title":"(\u2212)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer\u2019s disease","volume":"28","author":"Guo","year":"2017","journal-title":"Neuroreport"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b1555","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700890","article-title":"Epigallocatechin gallate reduces amyloid \u03b2\u2010induced neurotoxicity via inhibiting endoplasmic reticulum stress\u2010mediated apoptosis","volume":"62","author":"Du","year":"2018","journal-title":"Molecular Nutrition & Food Research"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b1560","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1074\/jbc.RA118.004280","article-title":"Combined treatment with the phenolics (\u2212)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice","volume":"294","author":"Mori","year":"2019","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.brainres.2025.149693_b1565","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s12035-019-01849-6","article-title":"Epigallocatechin-3-Gallate (EGCG) improves cognitive deficits aggravated by an obesogenic diet through modulation of unfolded protein response in APPswe\/PS1dE9 mice","volume":"57","author":"Ettcheto","year":"2020","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1570","article-title":"Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6\u2010OHDA Model of Parkinson\u2019s Disease","volume":"2015","author":"Bitu Pinto","year":"2015","journal-title":"Evidence\u2010based Complementary and Alternative Medicine"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b1575","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1096\/fj.201903125RR","article-title":"EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson\u2019s disease","volume":"34","author":"Xu","year":"2020","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.brainres.2025.149693_b1580","doi-asserted-by":"crossref","unstructured":"T. R. Sampson et al., \u201cGut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease,\u201d Cell, vol. 167, no. 6, pp. 1469-1480. e12, 2016.","DOI":"10.1016\/j.cell.2016.11.018"},{"issue":"9","key":"10.1016\/j.brainres.2025.149693_b1585","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/ejcn.2017.89","article-title":"Gut microbiota composition in relation to the metabolic response to 12-week combined polyphenol supplementation in overweight men and women","volume":"71","author":"Most","year":"2017","journal-title":"European Journal of Clinical Nutrition"},{"issue":"36","key":"10.1016\/j.brainres.2025.149693_b1590","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1021\/acs.jafc.0c03587","article-title":"Reciprocal interactions between epigallocatechin-3-gallate (EGCG) and human gut microbiota in vitro","volume":"68","author":"Liu","year":"2020","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b1595","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s40265-020-01268-1","article-title":"Sodium oligomannate: first approval","volume":"80","author":"Syed","year":"2020","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b1600","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S1474-4422(19)30141-3","article-title":"Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial","volume":"18","author":"Levin","year":"2019","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.brainres.2025.149693_b1605","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-0-12-801238-3.11611-3","article-title":"Antioxidant therapy and neurodegenerative disorders: Lessons from clinical trials","volume":"2","author":"Silva","year":"2021","journal-title":"Syst. Med.(new Rochelle)"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b1610","doi-asserted-by":"crossref","first-page":"1700S","DOI":"10.3945\/ajcn.113.058248","article-title":"Acute effects of tea consumption on attention and mood","volume":"98","author":"Ein\u00f6ther","year":"2013","journal-title":"The American Journal of Clinical Nutrition"},{"issue":"8","key":"10.1016\/j.brainres.2025.149693_b1615","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/nure.12120","article-title":"Acute effects of tea constituents L-theanine, caffeine, and epigallocatechin gallate on cognitive function and mood: a systematic review and meta-analysis","volume":"72","author":"Camfield","year":"2014","journal-title":"Nutrition Reviews"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b1620","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/hup.1263","article-title":"Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance and mood in healthy humans: a double\u2010blind, placebo\u2010controlled, crossover investigation","volume":"27","author":"Wightman","year":"2012","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b1625","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.appet.2011.11.016","article-title":"Acute neurocognitive effects of epigallocatechin gallate (EGCG)","volume":"58","author":"Scholey","year":"2012","journal-title":"Appetite"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1630","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-022-00382-6","article-title":"Multiple system atrophy","volume":"8","author":"Poewe","year":"2022","journal-title":"Nature Reviews Disease Primers"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b1635","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41583-023-00697-7","article-title":"Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms","volume":"24","author":"Stefanova","year":"2023","journal-title":"Nature Reviews Neuroscience"},{"issue":"6","key":"10.1016\/j.brainres.2025.149693_b1640","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3177\/jnsv.43.679","article-title":"Absorption and distribution of tea catechin,(-)-epigallocatechin-3-gallate, in the rat","volume":"43","author":"Nakagawa","year":"1997","journal-title":"Journal of Nutritional Science and Vitaminology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1645","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.fct.2009.10.030","article-title":"Hepatotoxicity of high oral dose (\u2212)-epigallocatechin-3-gallate in mice","volume":"48","author":"Lambert","year":"2010","journal-title":"Food and Chemical Toxicology"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b1650","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/jpi.12281","article-title":"Melatonin attenuates (\u2010)\u2010epigallocatehin\u20103\u2010gallate\u2010triggered hepatotoxicity without compromising its downregulation of hepatic gluconeogenic and lipogenic genes in mice","volume":"59","author":"Wang","year":"2015","journal-title":"Journal of Pineal Research"},{"key":"10.1016\/j.brainres.2025.149693_b1655","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.toxrep.2016.03.001","article-title":"Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia","volume":"3","author":"Ramachandran","year":"2016","journal-title":"Toxicology Reports"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1660","doi-asserted-by":"crossref","first-page":"40617","DOI":"10.1038\/srep40617","article-title":"Nephro-toxic effects of intraperitoneally injected EGCG in diabetic mice: involvement of oxidative stress, inflammation and apoptosis","volume":"7","author":"Rasheed","year":"2017","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.brainres.2025.149693_b1665","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.crohns.2011.08.012","article-title":"Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis","volume":"6","author":"Br\u00fcckner","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1670","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pathophys.2009.07.004","article-title":"Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats","volume":"17","author":"Roghani","year":"2010","journal-title":"Pathophysiology"},{"issue":"3","key":"10.1016\/j.brainres.2025.149693_b1675","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.fct.2007.10.027","article-title":"28-Day oral (gavage) toxicity studies of green tea catechins prepared for beverages in rats","volume":"46","author":"Chengelis","year":"2008","journal-title":"Food and Chemical Toxicology"},{"issue":"10","key":"10.1016\/j.brainres.2025.149693_b1680","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.fct.2011.07.007","article-title":"A subacute toxicity evaluation of green tea (Camellia sinensis) extract in mice","volume":"49","author":"Hsu","year":"2011","journal-title":"Food and Chemical Toxicology"},{"issue":"1\u20133","key":"10.1016\/j.brainres.2025.149693_b1685","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tox.2009.03.007","article-title":"Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs","volume":"260","author":"Kapetanovic","year":"2009","journal-title":"Toxicology"},{"issue":"5","key":"10.1016\/j.brainres.2025.149693_b1690","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fct.2005.11.003","article-title":"Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies","volume":"44","author":"Isbrucker","year":"2006","journal-title":"Food and Chemical Toxicology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149693_b1695","article-title":"Effectiveness of green tea in a randomized human cohort: relevance to diabetes and its complications","volume":"2013","author":"Toolsee","year":"2013","journal-title":"BioMed Research International"},{"issue":"4","key":"10.1016\/j.brainres.2025.149693_b1700","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1024\/0300-9831.74.4.269","article-title":"Decourt, Girault, Spitzer, and Weber, \u201cPlasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers,\u201d","volume":"74","author":"Ullmann","year":"2004","journal-title":"International Journal for Vitamin and Nutrition Research"},{"issue":"7","key":"10.1016\/j.brainres.2025.149693_b1705","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1017\/S0007114513003784","article-title":"Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial","volume":"111","author":"Mielgo-Ayuso","year":"2014","journal-title":"British Journal of Nutrition"},{"key":"10.1016\/j.brainres.2025.149693_b1710","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00280-004-0859-1","article-title":"Phase I study of green tea extract in patients with advanced lung cancer","volume":"55","author":"Laurie","year":"2005","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1016\/j.brainres.2025.149693_b1715","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","article-title":"The safety of green tea and green tea extract consumption in adults\u2013results of a systematic review","volume":"95","author":"Hu","year":"2018","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.brainres.2025.149693_b1720","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.yrtph.2017.01.002","article-title":"Bioactive nutrients-time for tolerable upper intake levels to address safety","volume":"84","author":"Yates","year":"2017","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.brainres.2025.149693_b1725","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.toxlet.2017.06.008","article-title":"Safety assessment of green tea based beverages and dried green tea extracts as nutritional supplements","volume":"277","author":"Dekant","year":"2017","journal-title":"Toxicology Letters"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325002525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325002525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:06:57Z","timestamp":1767992817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899325002525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":344,"alternative-id":["S0006899325002525"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149693","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective potential of epigallocatechin gallate in Neurodegenerative Diseases: Insights into molecular mechanisms and clinical Relevance","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149693"}}